Pharmaceutics 2010, 2(4), 351-363; doi:10.3390/pharmaceutics2040351

Small Volume Dissolution Testing as a Powerful Method during Pharmaceutical Development

1 Biopharmaceutical department, Faculty of Pharmacy, University of Auvergne 28 Place H. Dunant, BP 38, 63001 Clermont-Ferrand, France 2 Galenical & Analytical Development, Pharmaceutical Division, F. Hoffmann-La Roche Ltd., CH-4070, Basel, Switzerland
* Author to whom correspondence should be addressed.
Received: 12 October 2010; in revised form: 26 October 2010 / Accepted: 28 October 2010 / Published: 1 November 2010
(This article belongs to the Special Issue Recent Developments and Future Perspectives in Dissolution Testing)
PDF Full-text Download PDF Full-Text [184 KB, uploaded 1 November 2010 12:11 CET]
Abstract: Standard compendia dissolution apparatus are the first choice for development of new dissolution methods. Nevertheless, limitations coming from the amount of material available, analytical sensitivity, lack of discrimination or biorelevance may warrant the use of non compendial methods. In this regard, the use of small volume dissolution methods offers strong advantages. The present study aims primarily to evaluate the dissolution performance of various drug products having different release mechanisms, using commercially available small volume USP2 dissolution equipment. The present series of tests indicate that the small volume dissolution is a useful tool for the characterization of immediate release drug product. Depending on the release mechanism, different speed factors are proposed to mimic common one liter vessel performance. In addition, by increasing the discriminating power of the dissolution method, it potentially improves know how about formulations and on typical events which are evaluated during pharmaceutical development such as ageing or scale–up. In this regard, small volume dissolution is a method of choice in case of screening for critical quality attributes of rapidly dissolving tablets, where it is often difficult to detect differences using standard working conditions.
Keywords: Dissolution; Small volume; Discrimination; Screening; Quality By Design

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Scheubel, E.; Lindenberg, M.; Beyssac, E.; Cardot, J.-M. Small Volume Dissolution Testing as a Powerful Method during Pharmaceutical Development. Pharmaceutics 2010, 2, 351-363.

AMA Style

Scheubel E, Lindenberg M, Beyssac E, Cardot J-M. Small Volume Dissolution Testing as a Powerful Method during Pharmaceutical Development. Pharmaceutics. 2010; 2(4):351-363.

Chicago/Turabian Style

Scheubel, Emmanuel; Lindenberg, Marc; Beyssac, Eric; Cardot, Jean-Michel. 2010. "Small Volume Dissolution Testing as a Powerful Method during Pharmaceutical Development." Pharmaceutics 2, no. 4: 351-363.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert